Search 
Search www.celgene.com
Submit
 United States
												
 Australia 
English
 Austria 
Deutsch
 Belgium 
Français
Nederlands
 Brazil 
Português
 Canada 
English
Français
 China 
简体中文
 Czech Republic 
Čeština
 Denmark 
Dansk
 Europe 
English
 Finland 
Suomi
 France 
Français
 Germany 
Deutsch
 Hungary 
Magyar
 Ireland 
English
 Italy 
Italiano
 Japan 
日本語
 Luxembourg 
Français
Nederlands
 Malaysia 
English
 Mexico 
Español
 Netherlands 
Nederlands
 Norway 
Norsk
 Poland 
Polski
 Portugal 
Português
 Russia 
Русский язык
 Singapore 
English
 Slovakia 
Slovenčina
 Slovenia 
Slovenčina
 South Korea 
한국어
 Spain 
Español
 Sweden 
Svenska
 Switzerland 
Deutsch
Français
 Taiwan 
繁體中文
 Thailand 
English
 Turkey 
Türk
 United Kingdom 
English
 United States 
English
About
Our Story
Awards & Recognition
Our Culture
Our Employees
Leadership
Senior Management
Board of Directors and Committees
Compliance
Code of Business Conduct and Ethics
Sunshine Act FAQ
California Declaration of Compliance
Vermont Prescriber Information
Authorized Distributor of Record Listing
General Conformity Certifications for Celgene Products
Corporate Reports
Diversity
Global Office Locations
Celgene Worldwide Markets
Diseases
Acute Myeloid Leukemia
Beta Thalassemia
Indolent NHL
Multiple Myeloma
Celgene Resources for Multiple Myeloma
Multiple Myeloma Timeline
Multiple Sclerosis
Myelodysplastic Syndromes
Myelofibrosis
Pancreatic Cancer
Celgene Resources for Pancreatic Cancer
Psoriasis and Psoriatic Arthritis
Therapies
Anti-counterfeiting
Research & Development
Pipeline
Medical Innovation
IMiDs
Anti-inflammatory Compounds
R&D Locations
Research Oncology
Celgene Incubator
Clinical Trials
Celgene-sponsored Trials
Investigator-initiated Trials
Clinical Trials Data Sharing
Celgene Global Drug Safety and Risk Management
Chrysalis
Pre-Approval Access
Celgene Medical Affairs
Medical Affairs Grants
Independent Medical Education Grants
Scientific Advancement Grants
Celgene Medical Information
Medical Information Request Form
Responsibility
Patients First
Patient Safety, Support & Advocacy
Patient Safety
Innovation Impact Awards
Research & Development
Advocacy Partnerships
Celgene Support for European Patient Organizations
EFPIA Spend Transparency Disclosure
Pre-Approval Access
Patient Support
Global Health
Access Accelerated
Celgene Cancer Care Links™
AMPATH: Building Healthcare Capacity For Patients in Africa
Neglected Tropical Diseases
R&D for Neglected Tropical Diseases
Employees & Community
Employees
Our Culture and Values
Employee Safety
Employee Wellness
Diversity
Celgene Community Initiatives
Funding
Healthcare Related Donations
Charitable & Philanthropic Donations
Sponsorships
Corporate Memberships
Exhibits
Independent Medical Education Grants
Scientific Advancement Grants
Funding FAQs
Funding Contact Us
Business with Integrity
Governance
Sustainability & CR Governance
Ethics & Business Conduct
Reportable Allegations
Filing an Online Report
Country Access Codes
Public Policy
Public Policy Priorities
Association Memberships
Political Contributions
Supply Chain
Suppliers
Celgene and the Sustainable Development Goals
Environment
2020 Environmental Goals
Environmental Management
Building Sustainably
CDP (Carbon Disclosure Project)
Value
Value and Innovation Framework Report
Celgene Pricing Principles
Newsroom
Media Contacts
Multimedia Library
REMS Fact Sheet
Celgene Position Papers
Press Releases
Cellular Immunotherapies
ASH Congress
Patients
Celgene Patient Support®
Online Patient Resources
REMS – Pharmacy Network
Glossary
Medical Professionals
Celgene Medical Information
Partnering
Philosophy to Partnering
Areas of Interest
Partner with Celgene
Investors
Careers
CAR T Therapies
Contact Us
Celgene is showcasing its leadership
in blood cancer research at the ASH annual meeting.

​
Do Lymphoma Subtypes
Make a Difference in Treatment Decisions?
Understanding disease differences may lead to more targeted treatments. 
Read More
Expanding Prevalence
of Beta-thalassemia
Countries around the world are preparing for a rise in cases. 
Read More
Grey Matter Loss May Predict
Disability and Cognitive Impairment in MS
Read More
Helping Veterans with Lung Cancer:
Screening and Treatment Advances
Read More
Some Pancreatic Cancer Patients 
Receive No Treatment
Treatments can only offer hope if patients and doctors discuss the options. 
Read More
Celgene 
Treatments
Find a Therapy
ABRAXANE®
			
IDHIFA®
			
ISTODAX®
			
OTEZLA®
			
POMALYST®
			
REVLIMID®
			
THALOMID®
			
VIDAZA®
			
Go To Therapies
			
Learn more about our portfolio of treatment and services
Pipeline
Helping people live longer, better, healthier lives.
Celgene 
Treatments
Find a Therapy
ABRAXANE®
			
IDHIFA®
			
ISTODAX®
			
OTEZLA®
			
POMALYST®
			
REVLIMID®
			
THALOMID®
			
VIDAZA®
			
Go To Therapies
			
Learn more about our portfolio of treatment and services
Pipeline
Helping people live longer, better, healthier lives.
November 13, 2018
The Key to Unlocking Innovation? Great Partnerships!
Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Pinterest
Value & Innovation Framework Report
Learn our holistic and long-term approach to the concept of value.
Patients
Learn about our commitment to and services for patients.
Responsibility
Learn how our business decisions reflect our values.
November 6, 2018
Celgene Named Among World’s Best Employers 2018
Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Pinterest
November 12, 2018
How Eosinophilic Esophagitis Affects Our Lives
Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Pinterest
November 2, 2018
New Survey Reveals Myelodysplastic Syndromes Leave Patients Feeling Fatigued
Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Pinterest
October 31, 2018
Celgene and Agios Win Prix Galien
Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Pinterest
October 29, 2018
Take a Deeper Look at Plaque Psoriasis
Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Pinterest
October 24, 2018
Louise Roe Shares Her Inside Perspective on Plaque Psoriasis
Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Pinterest
October 19, 2018
Light The Night Helps Lead the Way for Blood Cancer Research
Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Pinterest
October 11, 2018
People with Multiple Sclerosis Want More Information on Brain Atrophy
Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Pinterest
September 27, 2018
How This Metastatic Breast Cancer Survivor Told Her Family About Her Diagnosis
Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Pinterest
Value & Innovation Framework Report
Learn our holistic and long-term approach to the concept of value.
Patients
Learn about our commitment to and services for patients.
Responsibility
Learn how our business decisions reflect our values.
Follow Celgene
Celgene on Twitter
Celgene on Facebook
Celgene on LinkedIn
Celgene on YouTube
Celgene on Pinterest
About Celgene
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients. 
Global Network
HAVE A QUESTION OR CONCERN?
CONTACT US
Site Map
About
Therapies
Research & Development
Research Oncology
Responsibility
Newsroom
Pipeline
Value Hub
Patients
Medical Professionals
Partnering
Investors
Careers
Copyright © 2018 Celgene Corporation
Celgene Privacy Policy
Terms of Use
Newsroom
Media Contacts
Multimedia Library
REMS Fact Sheet
Chrysalis Fact Sheet
Celgene Position Papers
Press Releases
Cellular Immunotherapies
ASH Congress
X
You are now leaving www.CELGENE.com, a website provided by Celgene. This link will take you to a website to which this 
Privacy Policy
 does not apply. We encourage you to read the Privacy Policy of every website you visit. Celgene does not endorse and/or influence the content found on websites not owned/operated by Celgene.
Continue
To view 
Website
Cancel
To return to www.Celgene.com
These products may not be approved and/or licensed in all countries where this website is accessible. For information about Celgene products and services in countries other than the U.S., please contact the local office (as listed under the 
Global Network
).
Continue
To view 
Website
Cancel
To return to www.Celgene.com
X
Beware of fraudulent and misleading emails being sent by unauthorized persons for job interviews/offers at Celgene Corporation.  These messages are being sent to cheat individuals.   Celgene never requires any payment to be made by any candidate to Celgene or to any individual or agency as part of our recruitment process.  Celgene will never ask for bank account or credit card information pre-hire. Please report any such activity to 
Frank Marrero
. 
 For authentic information about Celgene’s hiring, please visit 
Celgene’s official careers website
.
Continue to Careers 
Go to Celgene.com 
X
The CSR synopses posting is for informational purposes only and is not intended to have any legally binding effect.
Continue
Go Back